ReviewOncogene2002
Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML.
Review in Oncogene, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed.
- Challenges and Opportunities in Developing Targeted Therapies for Triple Negative Breast Cancer.Biomolecules · 2023Review
- Design, synthesis, and anticancer activity of novel 4-thiazolidinone-phenylaminopyrimidine hybrids.Molecular diversity · 2021Article
- Repositioning antispasmodic drug Papaverine for the treatment of chronic myeloid leukemia.Pharmacological reports : PR · 2021Article
- A Broad Overview of Signaling inCancers · 2021Review
- Kinase impact assessment in the landscape of fusion genes that retain kinase domains: a pan-cancer study.Briefings in bioinformatics · 2018Article
- Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site.Leukemia · 2017Article
- A derivative of epigallocatechin-3-gallate induces apoptosis via SHP-1-mediated suppression of BCR-ABL and STAT3 signalling in chronic myelogenous leukaemia.British journal of pharmacology · 2015Article
- Hepatic stellate cells: central modulators of hepatic carcinogenesis.BMC gastroenterology · 2015Review
- American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2015Article
- Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer.Frontiers in oncology · 2015Review
- The serum tryptase test: an emerging robust biomarker in clinical hematology.Expert review of hematology · 2014Review
- The GIST of targeted therapy for malignant melanoma.Annals of surgical oncology · 2014Review
- Imagine a world without cancer.BMC cancer · 2014Article
- Real-time nanoscale proteomic analysis of the novel multi-kinase pathway inhibitor rigosertib to measure the response to treatment of cancer.Expert opinion on investigational drugs · 2013Review
- Extended adjuvant therapy with imatinib in patients with gastrointestinal stromal tumors : recommendations for patient selection, risk assessment, and molecular response monitoring.Molecular diagnosis & therapy · 2013Article
- Heterogeneity of gene expression in murine squamous cell carcinoma development-the same tumor by different means.PloS one · 2013Article
- S-glutathionylated serine proteinase inhibitors as plasma biomarkers in assessing response to redox-modulating drugs.Cancer research · 2012Article
- PDGF in gliomas: more than just a growth factor?Upsala journal of medical sciences · 2012Article
- Pharmacologic inhibition of mTOR antagonizes the cytotoxic activity of pemetrexed in non-small cell lung cancer.Journal of cancer research and clinical oncology · 2012Article
- Defective cell cycle checkpoints as targets for anti-cancer therapies.Frontiers in pharmacology · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
12476300What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.